Ozempic recall underway in Canada due to cracked glass

An Ozempic recall is underway in Canada due to a product lot that was impacted by broken glass.

According to a recall alert from the Government of Canada, the affected lot that has been impacted by the recall may contain cracked glass cartridges.

The recall advises anyone who fears they may have been affected to consult their health professional if they have any health concerns.

According to the recall, the affected product is Semaglutide 1.34 mg/ml from the brand Novo Nordisk. The impacted lot numbers are RZFFE55 and RZFFE56.

The Government of Canada has a few tips on what to do if you believe you’ve been impacted, including:

Verify whether or not your product is affected
Consult your healthcare provider before discontinuing your use of the product or if you have health concerns
Contact the recalling firm if you have questions about the recall
Report any side effects to Health Canada
Report other safety complaints to Health Canada

The Government of Canada has more information about the Ozempic recall on its website.